Taxonomy
OPIMEC is the Spanish acronym for an observatory that seeks to promote collaboration among clinicians, managers, policy makers, researchers, members of the public and others interested in improving chronic disease management complex (CDM) worldwide.
One of the main goals of this initiative is the creation of a global taxonomy that could act as a common language to support the identification, selection, classification and implementation of innovative practices in CDM.
Anyone can add comments and vote on them favoring the creation of new terms and a common language and collaborative manner. No registration is required to formally contribute to this effort. However, if you want to be recognized for their contributions, you can register as a member of the project http://www.opimec.org/registro/
If you are still not comfortable with the process required to contribute to the glossary, or need a more advanced help, you can send a message to http://www.opimec.org/contacto/.
This Taxonomy was inspired by multiple sources, particularly Krumholz et al [2]; The International Classification of Diseases (versions 9 and 10) [3][4] and Medical Subject Headings [5]. It benefited particularly by contributions from Alex Jadad, Laura O'Grady and Jackie Bender from the People, Health equity and Innovation (PHI) Group at the University of Toronto; Ross Upshur, Canada Research Chair in Primary Care Research Chair at the University of Toronto in Canada; Peter Sargious and Jennifer Painter from the Canadian Chronic Care Network; Jessie Venegas from Foresight Links Corporation [6] in the United Kingdom; Andres Cabrera from the Andalusian School of Public Health; and Francisco Martos from the Andalusian Health Service in Spain.
Table of contents
- Introducción
- 1. Chronic Diseases
- 1.1. Individual chronic diseases
- 1.1.1. Cerebro-vascular Disease/Stroke
- 1.1.2. Coronary Heart Disease and Cardiac Failure
- 1.1.3. Chronic Obstructive Pulmunary Disease (COPD) and Asthma
- 1.1.4. Dementia
- 1.1.5. Diabetes Mellitus
- 1.1.6. HIV/AIDS
- 1.1.7. Musculoskeletal Diseases/Rheumatic and Osteoarticular Disorders
- 1.1.8. Oncology/Cancer
- 1.1.9. Psychiatric Disease
- 1.1.10. Renal Disease
- 1.1.11. Other Frequent Diseases
- 1.1.12. Rare Diseases
- 1.2.Complex, Chronic Diseases (Polypathology)
- 1.2.1. Co-morbidity
- 1.2.2. Coexisting/concurrent Diseases
- 1.2.3. Confluent morbidity
- 2. Patient Population
- 2.1. Population Characteristics
- 2.2. Signs and Symptoms
- 2.3. Risk Status
- 2.4. Disability
- 2.5. Dependency
- 2.6. Non clinical Characteristics
- 2.7. Events
- 2.8.Registries
- 3. Recipient
- 3.1.Patient
- 3.2. Caregiver
- 3.3. Physicians and other healthcare professionals
- 4. Intervention Content
- 4.1. Drug Therapy
- 4.2. Surgical Procedures
- 4.3. Complementary Therapies
- 4.4. Other Conventional Therapies
- 4.5. Supportive Care
- 4.5.1. Palliative Care (Sympton Control)
- 4.5.2. Emotional and Psychological Support
- 4.5.3. Informational Support
- 4.5.4. Social Support
- 4.5.5. Financial Support
- 4.6. Educational Intervention
- 4.7. Remote Monitoring
- 4.8. Concordance
- 4.9. Medication Therapy Management
- 5. Delivery Personnel
- 5.1. Nurses
- 5.2. Physicians
- 5.3. Pharmacists
- 5.4. Social Workers
- 5.5.Registered Dietitians
- 5.6. Occupational Therapists
- 5.7. Radiation Therapists
- 5.8. Physical Therapists (Physiotherapists)
- 5.9. Psychologists
- 5.10. Case Managers/Care Coordinators
- 5.11.Ethicists
- 5.12. Massage Therapists
- 5.13. Others involved in health Service Delivery
- 5.14. Shared Competencies
- 5.15. Peer Support
- 5.16. Self-management
- 6. Method of Communication
- 6.1. Direct (In person)
- 6.2. Virtual/Remote (Telehealth/Telemedicine)
- 6.2.1.Real time or Synchronous
- 6.2.2. Store and forward or Asynchronous
- 7. Intensity and Complexity
- 7.1. Intensity
- 7.2. Complexity
- 8. Environment
- 8.1. Institucional/Health Facilities
- 8.1.1. Primary Care Centres
- 8.1.2. Hospitals
- 8.1.3. Long Term Care Facilities/Nursing Homes
- 8.1.4. Hospices
- 8.2. Other institutions
- 8.3. Non-institutional
- 8.3.1. Homes
- 8.3.2. Workplace
- 8.3.3. Schools
- 8.3.4. Other non-institutional
- 9. Outcome Measures
- 9.1. Clinical
- 9.2. Process
- 9.3. Satisfaction
- 9.4. Resources utilization
- 9.5. Other Outcomes
- 10. Provisional Terms
- 10.1. Continuum of Care Health Promotion
- 10.1.1. Health Promotion
- 10.1.2. Early Diagnosis
- 10.1.3. Therapy
- 10.1.4. Rehabilitation
- 10.1.5. Terminal care
- 10.1.6. Bereavement
- 10.2. Knowledge Management
- 10.2.1. Clinical Protocols
- 10.2.2. Critical Pathways
- 10.2.3. Practice Guidelines
- Contribuyentes
- Licencia Creative Commons
Add here the needed aids related to the editor
Introducción
Uno de los objetivos principales de OPIMEC es la creación de un glosario que pueda actuar como un lenguaje común para apoyar la identificación, selección, clasificación e implementación de prácticas innovadoras para la gestión de enfermedades crónicas. El uso de un lenguaje común permitirá establecer las características principales de cada práctica, facilitando la comparación con otras experiencias.
Este glosario colaborativo, global y vivo se encuentra relacionado con el capítulo ‘Lenguaje de la polipatología’ del libro ‘Cuando las personas viven con múltiples enfermedades crónicas: aproximación colaborativa hacia un reto global emergente’ y está inspirado en gran parte en la versión de taxonomía de Krumholz.
A continuación se muestran términos relacionados con las enfermedades crónicas complejas, desplándose en forma de árbol otros términos asociados.
1. Chronic Diseases
MeSH:Chronic Diseases (http://www.ncbi.nlm.nih.gov/sites/entrez...)
Chronic diseases are diseases of long duration and generally slow progression. Chronic diseases are the principal cause of death and disability in the world. The most common are cardiovascular diseases, cancer, chronic obstructive pulmonary disease and diabetes. Out of the 35 million people who died from chronic disease in 2005, half were under70 and half were women [7] http://www.who.int/topics/chronic_diseases/en/.
It is expected that by 2020 they will be responsible for 73% of deaths worldwide and 60% of the world’s disease burden (Report of the World Health Organization 2002: “reducing risks and promoting and healthy life style” [8] http://www.who.int/whr/2002/en/
Almost 80% of these deaths will happen in developing countries and will be related to life styles or biological factors potentially modifiable (e.g., high blood pressure or cholesterol levels, and obesity).
Chronic diseases are almost always incurable. Therefore, they cannot be treated. They can be managed.
According to the Chronic Disease Management initiative in British Columbia, Canada [9] http://www.health.gov.bc.ca/cdm/cdminbc/... "Chronic disease management (CDM) is a systematic approach to improving health care for people with chronic disease. Health care can be delivered more effectively and efficiently if patients with chronic diseases take an active role in their own care and providers are supported with the necessary resources and expertise to better assist their patients in managing their illness. CDM is an approach to health care that emphasizes helping individuals maintain independence and keep as healthy as possible through prevention, early detection, and management of chronic conditions, such as congestive heart failure, asthma, diabetes, and other debilitating illnesses.Chronic conditions impose challenges for those affected, their families and care providers. A patient's ability to follow medical advice, accommodate lifestyle changes, and access resources are all factors that influence successful management of an ongoing illness."
MeSH: Disease Management http://www.ncbi.nlm.nih.gov/sites/entrez?Db=mesh&Cmd=ShowDetailView&TermToSearch=68019468&ordinalpos=1&itool=EntrezSystem2.PEntrez.Mesh.Mesh_ResultsPanel.Mesh_RVDocSu including also the previous category Patient Care Management http://www.ncbi.nlm.nih.gov/sites/entrez
1.1.1. Cerebro-vascular Disease/Stroke
MeSH: Cerebrovascular Disorders (http://www.ncbi.nlm.nih.gov/sites/entrez) A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES; or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others MeSH: Stroke (http://www.ncbi.nlm.nih.gov/sites/entrez?Db=mesh&Cmd=ShowDetailView&TermToSearch=68020521&ordinalpos=1&itool=EntrezSystem2.PEntrez.Mesh.Mesh_ResultsPanel.Mesh_RVDocSum)
A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810) Year introduced: 2008 (2000)
1.1.2. Coronary Heart Disease and Cardiac Failure
MeSH:Coronary Heart Disease (http://www.ncbi.nlm.nih.gov/sites/entrez?Db=mesh&Cmd=ShowDetailView&TermToSearch=68003324&ordinalpos=2&itool=EntrezSystem2.PEntrez.Mesh.Mesh_ResultsPanel.Mesh_RVDocSum)
Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Year introduced: 2008 (1987)
MeSH:Chronic Cardiac Failure (http://www.ncbi.nlm.nih.gov/sites/entrez?Db=mesh&Cmd=ShowDetailView&TermToSearch=68006333&ordinalpos=1&itool=EntrezSystem2.PEntrez.Mesh.Mesh_ResultsPanel.Mesh_RVDocSum)
A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION A
Yearintroduced: 2008 (1966)
1.1.3. Chronic Obstructive Pulmunary Disease (COPD) and Asthma
MeSH:Chronic Obstructive Pulmonary Disease (http://www.ncbi.nlm.nih.gov/sites/entrez
A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA
A form of bronchial disorder associated with airway obstruction, marked by recurrent attacks of paroxysmal dyspnea, with wheezing due to spasmodic contraction of the bronchi.
1.1.4. Dementia
An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behaviour, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness. Year introduced: 1981(1963)
1.1.5. Diabetes Mellitus
MeSH:Diabetes Mellitus http://www.ncbi.nlm.nih.gov/sites/entrez?Db=mesh&Cmd=ShowDetailView&TermToSearch=68003920&ordinalpos=1&itool=EntrezSystem2.PEntrez.Mesh.Mesh_ResultsPanel.Mesh_RVDocSum
A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
1.1.6. HIV/AIDS
Acquired Immunodeficiency Syndrome. An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as definedby the CDC in 1993. Year introduced: 1983.
MeSH:HIV Infections (http://www.ncbi.nlm.nih.gov/sites/entrez?Db=mesh&Cmd=ShowDetailView&TermToSearch=68006678&ordinalpos=3&itool=EntrezSystem2.PEntrez.Mesh.Mesh_ResultsPanel.Mesh_RVDocSum
Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex ( ARC), to acquired immunodeficiency syndrome ( AIDS). Year introduced: 1990
Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. Year introduced: 1988
1.1.7. Musculoskeletal Diseases/Rheumatic and Osteoarticular Disorders
MeSH:Rheumatic Disease http://www.ncbi.nlm.nih.gov/sites/entrez?Db=mesh&Cmd=ShowDetailView&TermToSearch=68012216&ordinalpos=1&itool=EntrezSystem2.PEntrez.Mesh.Mesh_ResultsPanel.Mesh_RVDocSum
Disorders of connective tissue, especially the joints and related structures, characterized by inflammation,degeneration, or metabolic derangement. Year introduced: 1990
MeSH:Osteoarthritis (http://www.ncbi.nlm.nih.gov/sites/entrez?Db=mesh&Cmd=ShowDetailView&TermToSearch=68010003&ordinalpos=1&itool=EntrezSystem2.PEntrez.Mesh.Mesh_ResultsPanel.Mesh_RVDocSum
A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.
MeSH:Musculoskeletal Disease
Diseases of the muscles and their associated ligaments and other connective tissue and of the bones and cartilage viewed collectively. Year introduced: 1992
1.1.9. Psychiatric Disease
MeSH:Psychiatric Diseasehttp://www.ncbi.nlm.nih.gov/sites/entrez?Db=mesh&Cmd=ShowDetailView&TermToSearch=68001523&ordinalpos=1&itool=EntrezSystem2.PEntrez.Mesh.Mesh_ResultsPanel.Mesh_RVDocSum
Mental Disorder or Psychiatric illness manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function. Year introduced: use pre-explosion 1974-1997
1.1.10. Renal Disease
MeSH:Chronic Kidney Failure,
The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION
1.1.12. Rare Diseases
MeSH:Rare Diseases http://www.ncbi.nlm.nih.gov/sites/entrez
A large group of diseases which are characterized by a low prevalence in the population. They frequently are associated with problems in diagnosis and treatment.
1.2.1. Co-morbidity
MeSH: Comorbidity http://www.nlm.nih.gov/cgi/mesh/2008/MB_cgi?mode=&term=Comorbidity&field=entry
The presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival. As an example, an individual could live with multiple chronic conditions such as paralysis, incontinence, dementia and pain, all stemming from a single disease like multiple sclerosis.
Comordibity could be classified in three groups depending on the relation between the index disease and the accompanying conditions:
- Random. These are the comorbidities that occur together with a frequency no different than the individual prevalences multiplied together, that is to say the associations occur by chance. An example in our practice is the co-existence of hand warts and osteoarthritis.
- Consequential (classified in the literature as casual or complicated co-morbidity). These are conditions that are pathophysiologically part of the same process. it is no surprise to find that diabetes and hypertension occur together more than by chance, so these co morbidities, though interesting, are predictable.
- Cluster co-morbidity is the non random clustering of health conditions without an evident underlying pathophysiological cause. Here is the opportunity for new discoveries - either new understandings of pathophysiology, or a new appreciation of the nature of complexity.
1.2.3. Confluent morbidity
Confluent morbidity occurs when the number of chronic conditions and medications taken to control the chronic
condition prevent simple single causal identification of common symptoms such as weakness, fatigue, dizziness. In short, confluent morbidity occurs when disease manifestations and medication effects are inseparable. [10] (http://www.utoronto.ca/jcb/about/publications/bmc_hsr2005.pdf [11] (http://www.utoronto.ca/jcb/about/publications/pbm2005.pdf0
2.1. Population Characteristics
MeSH:Population Characteristics http://www.ncbi.nlm.nih.gov/sites/entrez
Qualities and characterization of various types of populations within a social or geographic group, with emphasis on demography, health status, and socioeconomic factors. Year introduced: 1998
2.2. Signs and Symptoms
MeSH:Signs and Symptoms http://www.ncbi.nlm.nih.gov/sites/entrez?Db=mesh&Cmd=ShowDetailView&TermToSearch=68012816&ordinalpos=4&itool=EntrezSystem2.PEntrez.Mesh.Mesh_ResultsPanel.Mesh_RVDocSum
Clinical manifestations that can be either objective when observed by a physician, or subjective when perceived by the patient. Year introduced: 1998
2.3. Risk Status
MeSH:Risk
The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavourable outcome. High-risk groups—such as older patients, patients with a history of prior hospitalizations, and patients with significant co morbidities—may experience fewer hospitalizations in re-sponse to disease management. Failure to account for the risk status of the target population can therefore lead to inappropriate comparisons between interventions.
Risk Status with respect to progression and complications related to a particular health condition must be distinguished from risk factors for the conditions, though there may be overlap. For example, obesity may constitute an element affecting risk status as well as a risk factor as relates to diabetes. Positive family history would be a risk factor but not influence risk status.
2.5. Dependency
MeSH:Dependency http://www.ncbi.nlm.nih.gov/sites/entrez
The tendency of an individual or individuals to rely on others for advice, guidance, or support. Year introduced: 1991(1975) – For people living with chronic diseases, dependency tends to be a permanent, irreversible situation, thereby they need others to complete basic activities of daily living, as they have lost their physical, mental or social autonomy.2.6. Non clinical Characteristics
There are several aspects of people's lives that can have a profound influence on their health status and the way in which they cope with chronic conditions. These include gender, educational level, marital status, involvement in religious activities, socio-economic status, degree of perceived control over day-to-day decisions.
2.7. Events
The encounters of a person living with chronic diseases as recorded in health service databases. "High event" patients are those who have experienced three or more acute care hospitalizations as a result of their chronic illness. Those with complex, chronic conditions who have repeated hospital admissions or visits to the emergency department are also known as "frequent flyers" [12]
http://www.dmconf.com.sg/2008/slides/8_May/8_May_Ballroom2/P2%20Marco%20Bonollo.pdf2.8.Registries
MeSH:Registries
http://www.ncbi.nlm.nih.gov/sites/entrez
Entry Terms: Registry, Parish Registers, Parish Register, Register, Paris,Population Register, Population Registers,Register Population The systems and processes involved in the establishment, support, management, and operation of registers, e.g., disease registers. Year introduced: 1972(1969) - Updated lists of patients with a particular condition are also an important element of proactive chronic disease management. These registries may be developed at a practice or program level though the evolution to
population based management strategies has increased the discussion of geographic or jurisdictional registries. Suchregistries require strong policy and, in some instances, legislative frameworks.
3. Recipient
Usually, the person who is targeted by the intervention is the same that is expected to benefit from it. For instance, a medication prescribed to a patient with high blood pressure is meant to benefit such patient. However, in other situations the intervention could target a caregiver or even a health professional, who indirectly would benefit the patient.
3.1.Patient
MeSH:Patient http://www.ncbi.nlm.nih.gov/sites/entrez
Individuals participating in the health care system for the
purpose of receiving therapeutic, diagnostic, or preventive procedures.
3.2. Caregiver
Persons who provide care to those who need supervision or assistance in illness or disability. They may provide the care in the home, in a hospital, or in an institution. Although caregivers include trained medical, nursing, and other health personnel, the concept also refers to parents, spouses, or other family members, friends, members of the clergy, teachers, social workers, fellow patients, etc. (see below) Year introduced: 1992
4. Intervention Content
Used with diseases for therapeutic interventions except drug therapy, diet therapy, radiotherapy, and surgery, for which specific subheadings exist. The concept is also used for articles and books dealing with multiple therapies. Disease management interventions range widely from a single educational session to remote electronic monitoring to comprehensive programs involving multidisciplinary care teams. This variety reflects the perspective of those providing the intervention (e.g., physician, nurse, or pharmacist), issues specific to the patient population, and the
goals of the funding organization)
4.2. Surgical Procedures
MeSH:Surgical Procedures http://www.ncbi.nlm.nih.gov/sites/entrez?Db=mesh&Cmd=ShowDetailView&TermToSearch=68013514&ordinalpos=3&itool=EntrezSystem2.PEntrez.Mesh.Mesh_ResultsPanel.Mesh_RVDocSum
Operations carried out for the correction of deformities and defects, repair of injuries, and diagnosis and cure of certain diseases. Year introduced: 1998(1963)
4.3. Complementary Therapies
MeSH:Complementary Therapies http://www.ncbi.nlm.nih.gov/sites/entrez?Db=mesh&Cmd=ShowDetailView&TermToSearch=68000529&ordinalpos=1&itool=EntrezSystem2.PEntrez.Mesh.Mesh_ResultsPanel.Mesh_RVDocSum
Therapeutic practices which are not currently considered an integral part of conventional allopathic medical practice.
They may lack biomedical explanations but as they become better researched some (PHYSICAL THERAPY MODALITIES; DIET; ACUPUNCTURE) become widely accepted whereas others (humors, radium therapy) quietly fade away, yet are important historical footnotes. Therapies are termed as Complementary when used in addition to conventional treatments and as Alternative when used instead of conventional treatment. Year introduced: 2002(1986)
4.5.3. Informational Support
MeSH: Social Support
Support systems that provide assistance and encouragement to individuals with physical or emotional disabilities inorder that they may better cope. Informal social support is usually provided by friends, relatives, or peers, whileformal assistance is provided by churches, groups, etc. Year introduced: 1991(1983)
4.5.4. Social Support
MeSH: Social Support
Support systems that provide assistance and encouragement to individuals with physical or emotional disabilities in order that they may better cope. Informal social support is usually provided by friends, relatives, or peers, while
formal assistance is provided by churches, groups, etc. Year introduced: 1991(1983)
4.5.5. Financial Support
MeSH: Financial Support
http://www.ncbi.nlm.nih.gov/sites/entrez
The provision of monetary resources including money or capital and credit; obtaining or furnishing money or capital for a purchase or enterprise and the funds so obtained. (From Random House Unabridged Dictionary, 2d ed.) Year introduced: 1996
4.7. Remote Monitoring
MeSH:Monitoring, Ambulatory http://www.ncbi.nlm.nih.gov/sites/entrez
The use of electronic equipment to observe or record physiologic processes while the patient undergoes normal daily activities. Refers to the measurement of physiological processes such as vital signs (heart rate, respiration, blood pressure, temperature) and other measurements (blood cells, blood chemistry, renal output, etc) at a distance using digital and analog technology.
4.8. Concordance
This term refers to an interaction between a health care provider and a person living with chronic conditions (and or their family/support person (s) whereby the implementation or use of an intervention is negotiated from the perspective of both best health evidence and outcomes, and preferences. Older related terms include compliance, adherence and joint decision-making.
4.9. Medication Therapy Management
MesH :Medication Therapy Management (http://www.ncbi.nlm.nih.gov/mesh/68054539?ordinalpos=1&itool=EntrezSystem2.PEntrez.Mesh.Mesh_ResultsPanel.Mesh_RVDocSum)
Assistance in managing and monitoring drug therapy for patients receiving treatment for cancer or chronic conditions such as asthma and diabetes, consulting with patients and their families on the proper use of medication; conducting wellness and disease prevention programs to improve public health; overseeing medication use in a variety of settings.
5.5.Registered Dietitians
Registered dietitians are uniquely trained to give advice on food, diet and nutrition. Registration within a regulatory body assures the public and employers that an individual has met the standards for academic and practical experience required for the practice of the profession of dietetics.
5.6. Occupational Therapists
Personnel who work in occupational therapy, the field concerned with utilizing craft or work activities in the rehabilitation of patients. Occupational therapy can also refer to the activities themselves.
Professionals who evaluate the self-care, work and leisure skills of a person and plans and implements social and interpersonal activities to develop, restore, and/or maintain the person's ability to accomplish activities of daily living (eating, dressing, bathing) and necessary occupational tasks [13] (http://www.jimadler.com/en/legal-helpcen...
glossary-of-legal-terms.html)
5.7. Radiation Therapists
Radiotherapy http://www.ncbi.nlm.nih.gov/sites/entrez...
Individual involved in the therapeutic use of ionizing and
nonionizing radiation. It includes the use of radioisotope therapy. Year introduced: 1966
5.9. Psychologists
Psychological Techniques http://www.ncbi.nlm.nih.gov/sites/entrez?Db=mesh&Cmd=ShowDetailView&TermToSearch=68011580&ordinalpos=1&itool=EntrezSystem2.PEntrez.Mesh.Mesh_ResultsPanel.Mesh_RVDocSum
Individuals involved in the diagnosis and treatment of behavioral, personality, and mental disorders. Year introduced: 1998
5.10. Case Managers/Care Coordinators
A traditional term for all the activities which a physician or other health care professional normally performs to insure the coordination of the medical services required by a patient. It also, when used in connection with managed care, covers all the activities of evaluating the patient, planning treatment, referral, and follow-up so that care is continuous and comprehensive and payment for the care is obtained. (From Slee & Slee, Health Care Terms, 2nd ed)Year introduced: 1996.
Individuals responsible for generating, planning, organizing, and monitoring the provision of services for patients.
5.11.Ethicists
MeSH: Ethicists (http://www.ncbi.nlm.nih.gov/sites/entrez...) Persons trained in philosophical or theological ethics who work in clinical, research, public policy, or other settings where they bring their expertise to bear on the analysis of ethical dilemmas in policies or cases. Year introduced: 2002
5.12. Massage Therapists
MeSH: Massage (http://www.ncbi.nlm.nih.gov/sites/entrez...) Professionals who perform manipulations of body tissues for the purpose of affecting the nervous and muscular systems and the general circulation.
6.2. Virtual/Remote (Telehealth/Telemedicine)
MeSH:Remote Consultation http://www.ncbi.nlm.nih.gov/sites/entrez
Delivery of health services via remote telecommunications. This includes interactive consultative and diagnostic services. Year introduced: 1993
This category also includes telemonitoring, an approach that combines various information technologies for capturing, transmitting and analyzing physiological variables from patients with chronic conditions across long distances; and virtual communities (e.g., wikis, mailing lists, bulletin boards and other online social networks).
6.2.1.Real time or Synchronous
Real-time telehealth involves the use of information and communication technologies (e.g., a minimum set of video cameras, computer displays, and a secure high-speed Internet connection) to enable individuals to communicate live (or synchronously) over long and short distances [14] (http://cadth.ca/index.php/en/publication/788)Much simpler technologies could also be used for real-time support. For instance, the telephone can be a powerful tool to optimize
the assessment, planning, provision of information as well as support, evaluation, and documentation across long distances. (Government of the Northwest Territories Department of Health Policies and Guidelines for Community Health Nurses, Canada, 2008)
6.2.2. Store and forward or Asynchronous
Asynchronous telehealth refers to the storage of clinically important digital samples and relevant data from any location and forwarding them to a health care professional at a distant site for assessment at a convenient time [15] (http://cadth.ca/index.php/en/publication/789) . It is also known as store-and-forward telehealth. With the widespread
penetration of the Internet, the reduction in cost of data storage and the proliferation of digital cameras, patients who own Web cameras could request routine consultations with health professionals from home. Telephones with cameras are making multimedia teleconsultations possible from anywhere [16]
(http://www.cmaj.ca/cgi/content/full/171/12/1457)
7.2. Complexity
The number of diversity of the components of chronic disease management interventions, the extent to which they relate to each other. The term also includes the degree of information exchange among patients, caregivers and health professionals (Information Complexity) [17] (http://www.utoronto.ca/jcb/about/publications/bmc_hsr2005.pdf) [18]
(http://www.utoronto.ca/jcb/about/publications/pbm2005.pdf0) , the time consumed by the interventions (Time Management Complexity) [19] (http://www.utoronto.ca/jcb/about/publications/bmc_hsr2005.pdf) [20] (http://www.utoronto.ca/jcb/about/publications/pbm2005.pdf0) , and the extent to which nuanced discussions and deliberations are required to handle the uncertainty associated with the probability of outcomes relating to diagnostic
or therapeutic interventions (Interpretive Complexity) [21] (http://www.utoronto.ca/jcb/about/publications/bmc_hsr2005.pdf) [22] (http://www.utoronto.ca/jcb/about/publications/pbm2005.pdf0) .
8.1. Institucional/Health Facilities
MeSH:Health Facilities (http://www.ncbi.nlm.nih.gov/sites/entrez?Db=mesh&Cmd=ShowDetailView&TermToSearch=68006268&ordinalpos=1&itool=EntrezSystem2.PEntrez.Mesh.Mesh_ResultsPanel.Mesh_RVDocSum)
Institutions which provide medical or health-related services.
8.1.1. Primary Care Centres
Settings where integrated, accessible health care services are provided by clinicians who are accountable for addressing a large majority of personal health care needs, developing a sustained partnership with patients, and practicing in the context of family and community [See Primary Health Care]
(http://www.ncbi.nlm.nih.gov/sites/entrez...).
8.1.2. Hospitals
Hospitals (http://www.ncbi.nlm.nih.gov/sites/entrez... TermToSearch=68006761&ordinalpos=1 itool=EntrezSystem2.PEntrez.Mesh.Mesh_ResultsPanel.Mesh_RVDocSum)
Institutions with an organized medical staff which provide medical care to patients.











